Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bryostatin-1 + Paclitaxel in NSCLC
NCT00005849Phase 2Completed
- Sponsor
- University of Chicago
- Start
- Apr 2000
- Primary completion
- Sep 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bryostatin-1 in non-small cell lung cancer (NSCLC), sponsored by University of Chicago. Started Apr 2000; status: completed.
02
Drugs
bryostatin-1
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00005849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005849.